Medicare Enrolled
Dr. Rameshkumar Raman, M.D.
Endocrinology · Moline, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Raman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raman
Dr. Rameshkumar Raman is an endocrinology specialist in Moline, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Raman performed 10,780 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Raman received a total of $157,781 from 48 pharmaceutical and/or device companies across 760 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in IL
$157,781 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗10,780
Medicare services
Top 3% in IL for endocrinology
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,960 | $19 | $34 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,821 | $87 | $245 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
595 | $25 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
551 | $61 | $165 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
246 | $77 | $360 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
225 | $10 | $60 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
84 | $36 | $100 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
72 | $37 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $115 | $380 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
52 | $100 | $320 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 30 | $20 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $28 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $131 | $335 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
23 | $94 | $425 |
| New patient office visit, complex (60-74 min) | 12 | $167 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$157,781
Total received (2018-2024)
Avg $22,540/year across 7 years
Top 5% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
760
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$544
2023
$9,529
2022
$36,384
2021
$14,369
2020
$13,186
2019
$28,506
2018
$55,262
Payments by company (2024)
Amgen Inc.
$90
Dexcom, Inc.
$63
Lilly USA, LLC
$61
Novo Nordisk Inc
$57
Insulet Corporation
$36
Antares Pharma, Inc.
$33
Medtronic, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Ascensia Diabetes Care Us Inc.
$28
Tandem Diabetes Care, Inc.
$22
Abbott Laboratories
$21
BETA BIONICS, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Chiesi USA, Inc.
$15
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$91,649
AstraZeneca Pharmaceuticals LP
$26,102
Bayer HealthCare Pharmaceuticals Inc.
$14,525
SANOFI-AVENTIS U.S. LLC
$9,954
Dexcom, Inc.
$5,015
AbbVie, Inc.
$2,455
Bayer Healthcare Pharmaceuticals Inc.
$2,157
Amgen Inc.
$824
Lilly USA, LLC
$781
Abbott Laboratories
$662
Boehringer Ingelheim Pharmaceuticals, Inc.
$505
Tandem Diabetes Care, Inc.
$311
Merck Sharp & Dohme Corporation
$304
Medtronic, Inc.
$236
Shire North American Group Inc
$205
Corcept Therapeutics
$187
Novartis Pharmaceuticals Corporation
$169
Horizon Therapeutics plc
$164
Janssen Pharmaceuticals, Inc
$152
Medtronic MiniMed, Inc.
$147
Radius Health, Inc.
$133
Regeneron Healthcare Solutions, Inc.
$123
Bigfoot Biomedical Inc
$115
Valeritas, Inc.
$86
AbbVie Inc.
$78
Amarin Pharma Inc.
$74
Insulet Corporation
$66
Xeris Pharmaceuticals, Inc.
$61
Antares Pharma, Inc.
$58
DEXCOM, INC.
$51
Alexion Pharmaceuticals, Inc.
$50
Kowa Pharmaceuticals America, Inc.
$50
ABBVIE INC.
$38
Amryt Pharma Holdings Ltd
$34
Supernus Pharmaceuticals, Inc.
$33
Ascensia Diabetes Care Us Inc.
$28
MannKind Corporation
$24
Companion Medical, Inc.
$22
BETA BIONICS, INC.
$21
Mannkind Corporation
$18
Merck Sharp & Dohme LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Ascensia Diabetes Care US Inc.
$16
Chiesi USA, Inc.
$15
IBSA Pharma Inc.
$15
Acerta Pharma LLC
$13
Currax Pharmaceuticals LLC
$12
Eisai Inc.
$12
Top 3 companies account for 83.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · Belviq · CONTOUR NEXT ONE Meter · CONTRAVE · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RYBELSUS · Repatha · Rybelsus · SEGLUROMET · SOLIQUA · SOLIQUA 100/33 · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
9
County median income
$66,768
Nearest hospital to ZIP centroid (approximate)
GENESIS HLTH SYSTEM DBA GENESIS MDL CTR-ILLINI
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Raman is a clinical cardiology specialist, with above-average Medicare volume (top 3% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Raman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Raman performed 6,960 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raman receive payments from pharmaceutical companies?
Yes. Dr. Raman received a total of $157,781 from 48 companies across 760 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raman's costs compare to other endocrinologists in Moline?
Dr. Raman's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Moline
Browse endocrinologists in Moline ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in IL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in IL
Which IL endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology